205 related articles for article (PubMed ID: 19644164)
1. Early onset post transplantation lymphoproliferative disorders: analysis of international data from 5 studies.
Khedmat H; Taheri S
Ann Transplant; 2009; 14(3):74-7. PubMed ID: 19644164
[TBL] [Abstract][Full Text] [Related]
2. Late onset post transplantation lymphoproliferative disorders: analysis of international data from 5 studies.
Khedmat H; Taheri S
Ann Transplant; 2009; 14(4):80-5. PubMed ID: 20009160
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and prognosis of post-transplant lymphoproliferative disorders within renal allograft: Report from the PTLD.Int. Survey.
Khedmat H; Taheri S
Ann Transplant; 2010; 15(3):80-6. PubMed ID: 20877272
[TBL] [Abstract][Full Text] [Related]
4. Features, predictors and prognosis of lymphoproliferative disorders post-liver transplantation regarding disease presentation time: report from the PTLD.Int. survey.
Izadi M; Taheri S
Ann Transplant; 2011; 16(1):39-47. PubMed ID: 21436773
[TBL] [Abstract][Full Text] [Related]
5. Small intestinal involvement by lymphoproliferative disorders post-renal transplantation: a report from the post-transplant lymphoproliferative disorder international survey.
Khedmat H; Taheri S
Saudi J Kidney Dis Transpl; 2013 May; 24(3):487-94. PubMed ID: 23640619
[TBL] [Abstract][Full Text] [Related]
6. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ; Homan van der Heide JJ; Veeger NJ; Kluin PM; Kluin-Nelemans HC
Clin Transplant; 2005 Jun; 19(3):327-34. PubMed ID: 15877793
[TBL] [Abstract][Full Text] [Related]
7. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
[TBL] [Abstract][Full Text] [Related]
8. Post-transplantation lymphoproliferative disorders (PTLD) localized in the central nervous system: report from an international survey on PTLD.
Khedmat H; Taheri S
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):235-42. PubMed ID: 23538344
[TBL] [Abstract][Full Text] [Related]
9. Post-transplantation lymphoproliferative disorders localizing in the adenotonsillar region: report from the PTLD.Int survey.
Khedmat H; Taheri S
Ann Transplant; 2011; 16(1):109-16. PubMed ID: 21436784
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow involvement by lymphoproliferative disorders after renal transplantation: PTLD. Int. Survey.
Izadi M; Fazel M; Saadat SH; Taheri S
J Cancer Res Ther; 2012; 8(1):62-7. PubMed ID: 22531516
[TBL] [Abstract][Full Text] [Related]
11. More benign lymphoproliferative disease after liver transplant in infants.
Khedmat H; Ghamar-Chehreh ME; Amini M; Taheri S
Prog Transplant; 2013 Jun; 23(2):158-64. PubMed ID: 23782664
[TBL] [Abstract][Full Text] [Related]
12. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience.
Mendizabal M; Marciano S; dos Santos Schraiber L; Zapata R; Quiros R; Zanotelli ML; Rivas MM; Kusminsky G; Humeres R; Alves de Mattos A; Gadano A; Silva MO
Clin Transplant; 2013; 27(4):E469-77. PubMed ID: 23758407
[TBL] [Abstract][Full Text] [Related]
13. Significance of Epstein-Barr virus infection in the outcome of renal transplant patients with lymphoproliferative disorders.
Khedmat H; Alavian S; Taheri S
Ann Transplant; 2010; 15(2):40-4. PubMed ID: 20657518
[TBL] [Abstract][Full Text] [Related]
14. Ultra-early onset post-transplantation lymphoproliferative disease.
Khedmat H; Taheri S
Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1144-52. PubMed ID: 24231475
[TBL] [Abstract][Full Text] [Related]
15. Incidence of post-transplantation lymphoproliferative disease in Andalusia (1990-2009).
Govantes MA; Esteve AF; Ramos MT; Gracia De Guindo MC; Sánchez LF; Blanca MA; Rodríguez-Benot A; Blandino MV; De la Nuez PC; Rodríguez DB
Transplant Proc; 2013; 45(10):3592-4. PubMed ID: 24314968
[TBL] [Abstract][Full Text] [Related]
16. Heart allograft involvement by posttransplant lymphoproliferative disorders: report from the PTLD. Int survey.
Khedmat H; Taheri S
Exp Clin Transplant; 2011 Aug; 9(4):258-64. PubMed ID: 21819371
[TBL] [Abstract][Full Text] [Related]
17. Very late onset lymphoproliferative disorders occurring over 10 years post-renal transplantation: PTLD.Int. Survey.
Khedmat H; Taheri S
Hematol Oncol Stem Cell Ther; 2011; 4(2):73-80. PubMed ID: 21727768
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of post-transplant lymphoproliferative disorder after kidney transplantation versus hematopoietic stem cell transplantation.
Yoon JH; Lee S; Kim HJ; Lee JW; Min WS; Chung BH; Yang CW; Kim YS; Kim JI; Moon IS; Oh EJ; Park GS; Cho SG
Transpl Int; 2014 Jul; 27(7):721-32. PubMed ID: 24684689
[TBL] [Abstract][Full Text] [Related]
19. Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.
Trappe R; Riess H; Babel N; Hummel M; Lehmkuhl H; Jonas S; Anagnostopoulos I; Papp-Vary M; Reinke P; Hetzer R; Dörken B; Oertel S
Transplantation; 2007 Apr; 83(7):912-8. PubMed ID: 17460562
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival after post-transplant lymphoproliferative disease in children.
Nathanson S; Debray D; Delarue A; Deschênes G
Pediatr Nephrol; 2002 Aug; 17(8):668-72. PubMed ID: 12185479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]